Patient and Physician Predictors of Post-Fracture Osteoporosis Management

  • Adam E. Block
  • Daniel H. Solomon
  • Suzanne M. Cadarette
  • Helen Mogun
  • Niteesh K. Choudhry
Original Article

Abstract

Background

Undertreatment of osteoporosis after hip or wrist fracture has been well documented, but the reasons for current patterns of care are poorly understood.

Objective

We tested the role of physician and patient characteristics in predicting undertreatment when osteoporosis management was clearly indicated after a hip or wrist fracture in women over age 65.

Methods

We assembled a cohort of 9,698 female Medicare beneficiaries aged ≥65 years who experienced hip or wrist fracture between 2000 and 2004 and their prescribing physicians.

Measurements

The dominant prescriber was identified as the physician prescribing at least 50% of patient prescriptions in the year after the fracture. Multivariate logistic regression estimated the role of physician and patient characteristics on osteoporosis management after hip or wrist fracture.

Results

Patients older than 90 and black patients were less likely to be treated for osteoporosis relative to patients aged 65–69 and white patients. Female providers were more likely to manage osteoporosis. Models including patient characteristics discriminated well between managed and unmanaged patients (C statistic 0.81), while adding physician predictors to the model provided no additional discriminatory ability (C statistic 0.81).

Conclusions

Our findings highlight that osteoporosis management rates are similar across providers, but vary considerably by patient types.

KEY WORDS

osteoporosis fracture physician characteristics bisphosphonates patient characteristics 

References

  1. 1.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005 2025. J Bone Miner Res. 2007;22:465–75.PubMedCrossRefGoogle Scholar
  2. 2.
    Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003;115:398–400.PubMedCrossRefGoogle Scholar
  3. 3.
    Andrade SE, Majumdar SR, Chan KA, Buist SM, Go AS, Goodman M, et al. Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture. Arch Intern Med. 2003;163:2052–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med. 2005;142:260–W-30.PubMedGoogle Scholar
  5. 5.
    Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–105.PubMedCrossRefGoogle Scholar
  6. 6.
    Tu JV, Austin PC, Chan BTB. Relationship between annual volume of patients treated by admitting physician and mortality after acute myocardial infarction. JAMA. 2001;285:3116–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Epstein SA, Gonzales JJ, Weinfurt K, Boekeloo B, Yuan N, Chase G. Are psychiatrists’ characteristics related to how they care for depression in the medically Ill?: Results from a National Case-Vignette Survey. Psychosomatics. 2001;42:482–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Turchin A, Shubina M, Chodos AH, Einbinder JS, Pendergrass ML. Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus. Circulation. 2008;117:623–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Solomon DH, Brookhart MA, Gandhi TK, Karson A, Gharib S, Orav EJ, et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med. 2004;117:919–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Cadarette Sea. Access to osteoporosis treatment is critically linked to access to dual-energy X-ray absorptiometry testing. Med Care. 2007;45:6.CrossRefGoogle Scholar
  11. 11.
    Cadarette SMG, Monique AM, Jaglal SB, Beaton DB, Hawker GA. Access to osteoporosis treatment is critically linked to access to dual-energy X-Ray absorptiometry testing. Med Care. 2007;in press.Google Scholar
  12. 12.
    Ray WA, Griffin MR, Fought RL, Adams ML. Identification of fractures from computerized medicare files. J Clin Epidemiol. 1992;45:703–14.PubMedCrossRefGoogle Scholar
  13. 13.
    Choudhry NK, Soumerai SB, Normand S-LT, Ross-Degnan D, Laupacis A, Anderson GM. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med. 2006;119:607–15.PubMedCrossRefGoogle Scholar
  14. 14.
    Raiford DS, Gutthann SP, Garcia Rodriguez LA. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan Hospital Automated Database. [Article]. Epidemiology January 1996;7(1):101–104. 1996; 7: 101–04.Google Scholar
  15. 15.
    Piccola JE. Prescription drugs for senior citizens. Vol. 10/1/2007. State Senator Jeffrey Piccola, 15th District, PA.Google Scholar
  16. 16.
    Measuring Rurality. Washington DC: U.S. Department of Agriculture 2004.Google Scholar
  17. 17.
    Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med. 2003;115:715–20.PubMedCrossRefGoogle Scholar
  18. 18.
    Hosmer DaSL. Applied logistic regression, 2nd edn. New York City: John Wiley and Sons; 2000.Google Scholar
  19. 19.
    Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA. 2004;291:1864–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Institute of Medicine 2002.Google Scholar
  21. 21.
    Solomon D, Polinski J, Stedman M, Truppo C, Breiner L, Egan C, et al. Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med. 2007;22:362–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA, et al. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007;22:1808–15.PubMedCrossRefGoogle Scholar
  23. 23.
    Solomon DH, Morris C, Hailu C, Cabral D, Katz JN, Finkelstein JS, et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005;80:194–202.PubMedCrossRefGoogle Scholar
  24. 24.
    Macinko J SBaSL. Quantifying the health benefits of primary care phsycian supply in the United States. Int J Health Serv. 2007;37:16.CrossRefGoogle Scholar
  25. 25.
    Starfield B, Shi L, Grover A, Macinko J. The effects of specialist supply on populations’ health: assessing the evidence. Health Aff. 2005: hlthaff.w5.97.Google Scholar
  26. 26.
    Chen JRS, Wang Y, Radford MJ, Krumholz HM. Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction. J Gen Intern Med. 2006;21:7.Google Scholar
  27. 27.
    Epstein S. Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clinical Ther. 2006;28:151–73.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2008

Authors and Affiliations

  • Adam E. Block
    • 2
  • Daniel H. Solomon
    • 1
    • 3
  • Suzanne M. Cadarette
    • 1
  • Helen Mogun
    • 1
  • Niteesh K. Choudhry
    • 1
  1. 1.Division of Pharmacoepidemiology and PharmacoeconomicsBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA
  2. 2.Joint Committee on Taxation, US CongressWashingtonUSA
  3. 3.Division of RheumatologyBrigham and Women’s HospitalBostonUSA

Personalised recommendations